ในตอนนี้ เราจะเจาะลึกถึงความท้าทายในการนำเข้าเครื่องมือแพทย์เข้าสู่ตลาดบราซิล โดยเฉพาะข้อกำหนดการรับรองเพิ่มเติมจาก INMETRO สำหรับอุปกรณ์การแพทย์ไฟฟ้า และ ANATEL สำหรับอุปกรณ์ที่มีคุณสมบัติไร้สาย ซึ่งเป็นข้อบังคับที่นอกเหนือไปจากการอนุมัติโดย ANVISA ตามปกติ เราจะอธิบายถึงค่าใช้จ่ายและระยะเวลาที่เพิ่มขึ้นซึ่งเกี่ยวข้องกับใบรับรองเหล่านี้ และเหตุใดผู้ผลิตจึงจำเป็นต้องวางแผนอย่างรอบคอบเพื่อรับมือกับกฎระเบียบที่ซับซ้อนเหล่านี้- การขอใบรับรอง ANVISA

Trong tập này, chúng ta sẽ khám phá các yêu cầu chứng nhận bổ sung tại Brazil ngoài quy trình đăng ký ANVISA tiêu chuẩn. Chúng tôi sẽ đi sâu vào chứng nhận INMETRO đối với thiết bị y tế điện và chứng nhận ANATEL đối với các sản phẩm có tính năng không dây. Việc hiểu rõ các yêu cầu này là rất quan trọng để tránh sự chậm trễ và các chi phí không lường trước khi vào một trong những thị trường thiết bị y tế lớn nhất của Mỹ Latinh.- Chứng nhận INMETRO là gì và nó áp dụng cho những thiết bị y tế nào? -

Bu bölümde, Brezilya'nın medikal cihaz pazarına girerken sıkça gözden kaçırılan ek düzenleyici gereklilikleri ve maliyetleri ele alıyoruz. ANVISA onayı temel bir adım olsa da, elektromedikal cihazlar için zorunlu olan INMETRO sertifikasyonu ve kablosuz özelliklere sahip cihazlar için gereken ANATEL onayı gibi ek katmanları inceliyoruz. Bu sertifikasyonların zaman çizelgenizi ve bütçenizi nasıl etkileyebileceğini ve başarılı bir pazar girişi için neden proaktif bir stratejinin önemli olduğunu

Detta avsnitt utforskar de komplexa regulatoriska kraven för att lansera medicintekniska produkter i Brasilien. Vi går bortom det grundläggande ANVISA-godkännandet och belyser de obligatoriska och kostsamma tilläggscertifieringarna från INMETRO för elektromedicinsk utrustning och ANATEL för enheter med trådlös teknik. Lär dig om de specifika kostnaderna och hur dessa separata processer påverkar din tidslinje för marknadsinträde, samt varför en tidig och omfattande regulatorisk strategi är avgörande

यह एपिसोड ब्राजील के बाजार में चिकित्सा उपकरण लाने की प्रक्रिया को सरल बनाता है, जो प्रसिद्ध ANVISA पंजीकरण से आगे बढ़कर है। हम विशिष्ट उपकरणों के लिए आवश्यक अनिवार्य, अतिरिक्त प्रमाणपत्रों का पता लगाते हैं: इलेक्ट्रोमेडिकल उपकरणों के लिए INMETRO और वायरलेस क्षमताओं वाले उपकरणों के लिए ANATEL। संबंधित लागतों, समय-सीमाओं और सफल बाजार में प्रवेश के लिए ये कदम क्यों महत्वपूर्ण हैं, इसके बारे में जानें, जो आपकी कंपनी को संभावित देरी और अप्रत्याशित खर्चों से बचाता है।मुख्य प्रश्न: - ब्राजील में कई

In questo episodio, esploriamo il complesso processo di approvazione dei dispositivi medici in Brasile, che va ben oltre la sola registrazione ANVISA. Analizziamo i requisiti di certificazione obbligatori da parte di INMETRO per le apparecchiature elettromedicali e di ANATEL per i dispositivi con funzionalità wireless. Scoprirete come queste certificazioni aggiuntive incidono sulle tempistiche, sui costi e sulla strategia complessiva di accesso al mercato brasiliano.- L'approvazione ANVISA è

Neste episódio, mergulhamos nas complexidades muitas vezes negligenciadas do mercado brasileiro de dispositivos médicos. Descubra por que a aprovação da ANVISA é apenas o primeiro passo e aprenda sobre as certificações adicionais e obrigatórias do INMETRO para equipamentos eletromédicos e da ANATEL para dispositivos com funcionalidades sem fio (wireless), que adicionam custos e tempo significativos ao seu processo de entrada no mercado.- A aprovação da ANVISA é suficiente para vender o seu

Cet épisode explore les exigences de certification spécifiques pour les dispositifs médicaux au Brésil, au-delà de l'approbation standard d'ANVISA. Nous nous penchons sur les certifications obligatoires INMETRO pour les équipements électromédicaux et ANATEL pour les appareils sans fil, en détaillant les coûts, les délais et l'impact sur votre stratégie d'accès au marché.Questions Clés : - Qu'est-ce que la certification INMETRO et pourquoi est-elle cruciale pour les appareils électromédicaux au

He describes CUE-401, which combines a TGF-beta breathing-mask moiety with an interleukin (IL-2) mutein, and CUE-501, a Boehringer Ingelheim partnered program which is designed to deplete B-cells by painting them and engaging with virus-specific memory T-cells.

Sneak Peek: Innovating Tomorrow’s Medicine ft. Rick Fultz, CEO of Acurion, Inc. whose mission is to bring the power of precision medicine to more cancer patients, faster.In this exclusive preview, Rick shares a glimpse into how Acurion is transforming the field of precision oncology using next-generation science and strategic biotech leadership.➡️ Full episode launches on 30 October 🔔 Subscribe and hit the bell so you don’t miss it!🎙️ About the Show:Innovating Tomorrow’s Medicine features bold

In this episode of NCPDPunscripted, we sit down with Sean Kim, VP of Practice and Professional Development at the California Pharmacists Association, to talk about how pharmacists are stepping into expanded clinical roles and driving access to care across the state. From provider status and payment parity to long-acting injectables and community health worker programs, Sean shares how California is innovating to meet patients where they are. Hear how data sharing, collaboration, and evolving ...

In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to reject a petition calling for Tylenol label changes, and industry insights from Bob Mauch on building a stronger, more resilient pharmaceutical supply chain.

The FDA has criticized the industry for not taking advertising and promotion seriously and is now cracking down, as evidenced by hundreds of non-compliance letters. This raises the question: if similar scrutiny applied to clinical research, what would stand out first? Likely areas include proper informed consent, accurate recordkeeping, and potential upticks in physician enforcement. While this use of AI in research compliance hasn’t fully emerged yet, AI is already being applied in promotion...

Dr. Don and Professor Ben talk about the risks from eating canned pet food. Dr. Don - not risky 👍🏼  Professor Ben - not risky 👍🏼   Jim Nielsen: “My wife came home with a giant…” - Mastodon Nummy Tum-Tum Pure Organic Pumpkin Canned Dog & Cat Food Supplement | Chewy (Free Shipping) Whats the Difference Between Raw and Pasteurized Milk? Pet Food | FDA

Episode Highlights 1️⃣ Seek Support from Specialists – Learn which specialists to see: cardiologist, neurologist, developmental pediatrician, orthopedist, speech, occupational & physical therapists, and feeding specialists. – Contact your local school district early for early intervention services. – Visit our Glossary for common medical and therapy terms: med13l.org/resources – Ensure all providers use the MED13L ICD-10 Code (Q87.85) to correctly document and track care. 2️⃣ Be Count...

AABP Executive Director Dr. Fred Gingrich is joined by technical services veterinarians from Merck Animal Health, Dr. Jacque Fusilier and Dr. Dave Sjeklocha to discuss bovine respiratory disease (BRD) in beef cattle. BRD has long been a challenge in the cattle industry but today, we are taking a fresh look. From shifting market dynamics to evolving herd management practices, we explore what is driving BRD today and what steps we need to take to stay ahead. This episode of Have You Herd...

DNA damage is an inevitable consequence of biological processes and environmental exposure. Many types of DNA damage result from exposure to various chemicals, physical conditions, aging, or manipulation. From oxidation to deamination, modified bases can lead to mutagenic effects that put organisms at risk of disorder and disease.

👉 Para receber diretamente os áudios no seu celular, entre para o grupo: 🔗 https://site.vedanta.com.br/lead/cast-jz Saiba mais sobre esse conhecimento em: https://www.instagram.com/vedanta.soma

:)

Gościem odcinka jest Piotr Lisowski – tłumacz polskiej wersji GCP R3, która niedawno ukazała się na stronie Stowarzyszenia GCPpl.Rozmawiamy między innymi o tym:- jakie pojęcia i definicje wprowadza GCP R3- co stanowiło największą trudność w procesie tłumaczenia- na co powinniśmy zwracać szczególną uwagę korzystając z GCP R3